Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

CTLA-4 Blockade With MDX-010 to Induce Graft-Versus-Malignancy Effects Following Allogeneic Hematopoietic Stem Cell Transplantation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00060372
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:21.376398+00:00
Published At
2013-03-27T00:00:00+00:00
Record Updated At
2013-03-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities", "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)", "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)", "Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative", "Childhood Myelodysplastic Syndromes", "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Disseminated Neuroblastoma", "Malignant Neoplasm", "Ovarian Choriocarcinoma", "Ovarian Embryonal Carcinoma", "Ovarian Immature Teratoma", "Ovarian Mature Teratoma", "Ovarian Mixed Germ Cell Tumor", "Ovarian Monodermal and Highly Specialized Teratoma", "Ovarian Polyembryoma", "Ovarian Yolk Sac Tumor", "Previously Treated Myelodysplastic Syndromes", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent Adult Acute Myeloid Leukemia", "Recurrent Adult Burkitt Lymphoma", "Recurrent Adult Diffuse Large Cell Lymphoma", "Recurrent Adult Diffuse Mixed Cell Lymphoma", "Recurrent Adult Hodgkin Lymphoma", "Recurrent Adult Immunoblastic Large Cell Lymphoma", "Recurrent Adult Lymphoblastic Lymphoma", "Recurrent Grade 3 Follicular Lymphoma", "Recurrent Malignant Testicular Germ Cell Tumor", "Recurrent Mantle Cell Lymphoma", "Recurrent Neuroblastoma", "Recurrent Ovarian Epithelial Cancer", "Recurrent Ovarian Germ Cell Tumor", "Refractory Chronic Lymphocytic Leukemia", "Refractory Multiple Myeloma", "Relapsing Chronic Myelogenous Leukemia", "Stage I Multiple Myeloma", "Stage II Multiple Myeloma", "Stage II Ovarian Epithelial Cancer", "Stage III Malignant Testicular Germ Cell Tumor", "Stage III Multiple Myeloma", "Stage III Ovarian Epithelial Cancer", "Stage IIIA Breast Cancer", "Stage IIIB Breast Cancer", "Stage IIIC Breast Cancer", "Stage IV Breast Cancer", "Stage IV Ovarian Epithelial Cancer", "Testicular Choriocarcinoma", "Testicular Choriocarcinoma and Embryonal Carcinoma", "Testicular Choriocarcinoma and Seminoma", "Testicular Choriocarcinoma and Teratoma", "Testicular Choriocarcinoma and Yolk Sac Tumor", "Testicular Embryonal Carcinoma", "Testicular Embryonal Carcinoma and Seminoma", "Testicular Embryonal Carcinoma and Teratoma", "Testicular Embryonal Carcinoma and Teratoma With Seminoma", "Testicular Embryonal Carcinoma and Yolk Sac Tumor", "Testicular Embryonal Carcinoma and Yolk Sac Tumor With Seminoma", "Testicular Teratoma", "Testicular Yolk Sac Tumor", "Testicular Yolk Sac Tumor and Teratoma", "Testicular Yolk Sac Tumor and Teratoma With Seminoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-03-27"
protocolSection.identificationModule.nctId
"NCT00060372"
protocolSection.identificationModule.officialTitle
"CTLA-4 Blockade With MDX-010 to Induce Graft-Versus-Malignancy Effects Following Allogeneic Hematopoietic Stem Cell Transplantation"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) (protocolSection.conditionsModule.conditions)
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative (protocolSection.conditionsModule.conditions)
  • Childhood Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive (protocolSection.conditionsModule.conditions)
  • Disseminated Neuroblastoma (protocolSection.conditionsModule.conditions)
  • Malignant Neoplasm (protocolSection.conditionsModule.conditions)
  • Ovarian Choriocarcinoma (protocolSection.conditionsModule.conditions)
  • Ovarian Embryonal Carcinoma (protocolSection.conditionsModule.conditions)
  • Ovarian Immature Teratoma (protocolSection.conditionsModule.conditions)
  • Ovarian Mature Teratoma (protocolSection.conditionsModule.conditions)
  • Ovarian Mixed Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Ovarian Monodermal and Highly Specialized Teratoma (protocolSection.conditionsModule.conditions)
  • Ovarian Polyembryoma (protocolSection.conditionsModule.conditions)
  • Ovarian Yolk Sac Tumor (protocolSection.conditionsModule.conditions)
  • Previously Treated Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Burkitt Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Malignant Testicular Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Neuroblastoma (protocolSection.conditionsModule.conditions)
  • Recurrent Ovarian Epithelial Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Ovarian Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Refractory Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Refractory Multiple Myeloma (protocolSection.conditionsModule.conditions)
  • Relapsing Chronic Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • Stage I Multiple Myeloma (protocolSection.conditionsModule.conditions)
  • Stage II Multiple Myeloma (protocolSection.conditionsModule.conditions)
  • Stage II Ovarian Epithelial Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Malignant Testicular Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Stage III Multiple Myeloma (protocolSection.conditionsModule.conditions)
  • Stage III Ovarian Epithelial Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIC Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Ovarian Epithelial Cancer (protocolSection.conditionsModule.conditions)
  • Testicular Choriocarcinoma (protocolSection.conditionsModule.conditions)
  • Testicular Choriocarcinoma and Embryonal Carcinoma (protocolSection.conditionsModule.conditions)
  • Testicular Choriocarcinoma and Seminoma (protocolSection.conditionsModule.conditions)
  • Testicular Choriocarcinoma and Teratoma (protocolSection.conditionsModule.conditions)
  • Testicular Choriocarcinoma and Yolk Sac Tumor (protocolSection.conditionsModule.conditions)
  • Testicular Embryonal Carcinoma (protocolSection.conditionsModule.conditions)
  • Testicular Embryonal Carcinoma and Seminoma (protocolSection.conditionsModule.conditions)
  • Testicular Embryonal Carcinoma and Teratoma (protocolSection.conditionsModule.conditions)
  • Testicular Embryonal Carcinoma and Teratoma With Seminoma (protocolSection.conditionsModule.conditions)
  • Testicular Embryonal Carcinoma and Yolk Sac Tumor (protocolSection.conditionsModule.conditions)
  • Testicular Embryonal Carcinoma and Yolk Sac Tumor With Seminoma (protocolSection.conditionsModule.conditions)
  • Testicular Teratoma (protocolSection.conditionsModule.conditions)
  • Testicular Yolk Sac Tumor (protocolSection.conditionsModule.conditions)
  • Testicular Yolk Sac Tumor and Teratoma (protocolSection.conditionsModule.conditions)
  • Testicular Yolk Sac Tumor and Teratoma With Seminoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.